These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16248240)

  • 1. [Clinical research on combined therapy of diane-35 with modified yougui pill on polycystic ovarian syndrome].
    Chen LS; Zhou JT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Sep; 25(9):794-6. PubMed ID: 16248240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.
    Deng Y; Wang YF; Zhu SY; Ma X; Xue W; Ma RL; Sun AJ
    Chin J Integr Med; 2020 Dec; 26(12):883-889. PubMed ID: 32915426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
    Kuek S; Wang WJ; Gui SQ
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):965-72. PubMed ID: 21906521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
    Hwang JL; Seow KM; Lin YH; Huang LW; Hsieh BC; Tsai YL; Wu GJ; Huang SC; Chen CY; Chen PH; Tzeng CR
    Hum Reprod; 2004 Sep; 19(9):1993-2000. PubMed ID: 15284212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
    Chung JP; Yiu AK; Chung TK; Chan SS
    J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):166-71. PubMed ID: 24656700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
    Prelević GM; Puzigaća Z; Balint-Perić LA
    Ann N Y Acad Sci; 1993 May; 687():255-62. PubMed ID: 8323181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic efficacy of modified zigui decoction in treatment of polycystic ovary syndrome of gan-shen yin deficiency syndrome].
    Li XP; Lin S; Ye S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1070-3. PubMed ID: 21910337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of danzhi xiaoyao pill on ovulation induction of polycystic ovarian syndrome patients of pathogenic fire derived from stagnation of gan-qi].
    Liu Y; Mao LH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1191-5. PubMed ID: 24273971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
    Ruan X; Song J; Gu M; Wang L; Wang H; Mueck AO
    Arch Gynecol Obstet; 2018 Jun; 297(6):1557-1563. PubMed ID: 29602978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
    Luque-Ramírez M; Alvarez-Blasco F; Botella-Carretero JI; Martínez-Bermejo E; Lasunción MA; Escobar-Morreale HF
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2453-61. PubMed ID: 17426085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Cao Y; Zhang L; Zhao D; Liu Z
    Zhongguo Zhen Jiu; 2017 Jul; 37(7):710-714. PubMed ID: 29231543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Tartagni M; Schonauer LM; De Salvia MA; Cicinelli E; De Pergola G; D'Addario V
    Fertil Steril; 2000 Apr; 73(4):718-23. PubMed ID: 10731531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.
    Golland IM; Elstein ME
    Ann N Y Acad Sci; 1993 May; 687():263-71. PubMed ID: 8323182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined use of metformin and Diane35 in polycystic ovary syndrome].
    Mitkov M; Pekhlivanov B; Terzieva D
    Akush Ginekol (Sofiia); 2004; 43(3):34-7. PubMed ID: 15341255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R; Herer P; Shen-Orr Z
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
    Jing Z; Liang-Zhi X; Tai-Xiang W; Ying T; Yu-Jian J
    Gynecol Endocrinol; 2008 Oct; 24(10):590-600. PubMed ID: 19012104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
    Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
    Spona J; Huber J; Schmidt JB
    Geburtshilfe Frauenheilkd; 1986 Jul; 46(7):435-8. PubMed ID: 3093307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome.
    Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
    Fertil Steril; 2009 Jun; 91(6):2527-36. PubMed ID: 18565522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.